Evidence for an association between polymorphism in the serotonin-2A receptor variant (102T/C) and increment of N100 amplitude in schizophrenics treated with clozapine.
about
Activation of the JAK-STAT pathway by olanzapine is necessary for desensitization of serotonin2A receptor-stimulated phospholipase C signaling in rat frontal cortex but not serotonin2A receptor-stimulated hormone releaseThe promise and reality of pharmacogenetics in psychiatryPrefrontal executive function and D1, D3, 5-HT2A and 5-HT6 receptor gene variations in healthy adults.Pharmacogenetics in psychiatry: are we ready for widespread clinical use?Factors associated with response to clozapine in schizophrenia: a review.Pharmacogenetic considerations in the treatment of psychiatric disorders.Pharmacogenetics of response to antipsychotics in patients with schizophrenia.Toward understanding genetic risk for differential antipsychotic response in individuals with schizophrenia.Pharmacogenetics in schizophrenia: a review of clozapine studies.Pharmacogenetics of second-generation antipsychotics.Association analysis for MAOA gene polymorphism with long-latency auditory evoked potentials in healthy females.Association between schizophrenia and DRD3 or HTR2 receptor gene variants.Association analysis of serotonin 2A receptor gene T102c polymorphism and schizophrenia.Effects of chronic olanzapine and haloperidol differ on the mouse N1 auditory evoked potential.Association analysis for the C-1019G promoter variant of the 5-HT1A receptor gene with auditory evoked potentials in major depression.Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
P2860
Q33926752-C7D764BA-4EA4-4741-841F-178BC7477ED8Q35226451-5BFD879F-60AF-4C1E-B8DD-A666FD48F171Q36345284-FD9B19EA-8701-4C1D-B404-4F36F788E873Q37076472-6C5FBAB6-DDA0-4927-B454-2CE1B5859FECQ37300007-DB71C316-BD4F-42DD-A306-576860D42330Q37681573-4AA18D8C-7740-4464-8538-3ACE8E957DAEQ37952823-37F91B15-8234-44D1-87F5-0ED5D0C81E1AQ37960512-9EB9F5CD-5B17-4C1A-82D0-70172C479FA0Q38154175-C91DED15-CA32-4E0C-BD75-1CDAC9AEFE63Q38217628-92B7C581-72E6-4D4E-AF89-4DB8D6C32911Q40468694-430EEA23-C313-49A3-8FED-A8BCE8769033Q43456491-0C9675AC-A441-41D7-94FF-F939A1592B49Q44401607-2ECEE332-8DF4-4393-B9AD-D55F59522776Q44736082-59760F3D-4825-4F9A-B35A-D3A93AB4FEBFQ45148106-B9C39118-A584-4B98-B76A-242F77CA9BA3Q57491589-2B007BCC-E09E-4481-AF44-D6883BBC9218
P2860
Evidence for an association between polymorphism in the serotonin-2A receptor variant (102T/C) and increment of N100 amplitude in schizophrenics treated with clozapine.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Evidence for an association be ...... renics treated with clozapine.
@ast
Evidence for an association be ...... renics treated with clozapine.
@en
type
label
Evidence for an association be ...... renics treated with clozapine.
@ast
Evidence for an association be ...... renics treated with clozapine.
@en
prefLabel
Evidence for an association be ...... renics treated with clozapine.
@ast
Evidence for an association be ...... renics treated with clozapine.
@en
P2093
P356
P1433
P1476
Evidence for an association be ...... hrenics treated with clozapine
@en
P2093
P356
10.1159/000054871
P577
2001-01-01T00:00:00Z